A Peek Into The Markets: US Stock Futures Up Ahead Of Christmas Break

Pre-open movers

U.S. stock futures traded higher in early pre-market trade after the Dow Jones recorded a gain of over 100 points in the previous session. President Donald Trump vetoed the annual defense policy bill on Wednesday, which authorizes more than $740 billion in spending and outlines Pentagon policy. Markets will remain closed tomorrow for the Christmas Day holiday.

Futures for the Dow Jones Industrial Average climbed 81 points to 30,115.00 while the Standard & Poor’s 500 index futures traded rose 10.25 points to 3,691.75. Futures for the Nasdaq 100 index rose 18 points to 12,669.25.

The U.S. has the highest number of COVID-19 cases and deaths in the world, with total infections in the country exceeding 18,465,910 with around 326,210 deaths. India reported a total of at least 10,123,770 confirmed cases, while Brazil confirmed over 7,365,510 cases.

Oil prices traded lower as Brent crude futures fell 0.1% to trade at $51.18 per barrel, while US WTI crude futures fell 0.2% to trade at $48.05 a barrel. Crude supplies declined 562,000 barrels in the latest week, the Energy Information Administration said Wednesday.

A Peek Into Global Markets


European markets were higher today on prospects of Britain and the EU reaching a Brexit trade deal. The Spanish Ibex Index rose 0.2% and STOXX Europe 600 Index gained 0.2%. The French CAC 40 Index climbed 0.1%, while London’s FTSE 100 rose 0.1%.


Asian markets traded mostly higher today. Japan’s Nikkei 225 rose 0.54%, China’s Shanghai Composite fell 0.57%, Hong Kong’s Hang Seng Index gained 0.16% and India’s BSE Sensex rose 1.2%. Australia's S&P/ASX 200 traded higher by 0.3%.

 

Broker Recommendation

Analysts at Cantor Fitzgerald downgraded HMS Holdings Corp HMSY from Overweight to Neutral and announced a $37 price target.

HMS shares closed at $36.57 on Wednesday.


Breaking News

  • Altimmune Inc ALT reported that the FDA has issued a clinical hold on its Investigational New Drug application for its intranasal Covid-19 vaccine candidate, AdCOVID.
  • Senseonics Holdings Inc SENS lifted its sales guidance for the fourth quarter. The company said it now expects Q4 net sales of $3.5 million, versus prior forecast of $2.5 million.
  • Amedisys Inc AMED disclosed that its board has authorized a $100 million share repurchase program
  • SIFCO Industries Inc SIF reported a strong rise in its earnings for the fourth quarter.
Posted In: A Peek Into The MarketsEarningsNewsPenny StocksEurozoneFuturesSmall CapGlobalPre-Market OutlookMarkets

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.